EUVIMEDEUVIMED entdecken
Crossref

Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome

Ivy Ray, Binay Ray, Divya M.

International Journal of Pharmaceutical Quality Assurance · 11.07.2026 · 16 (12)

DOI: 10.25258/ijpqa.16.12.61 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 11.07.2026. Verfasst von Ivy Ray und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Ray, I., Ray, B., & M., D. (2026). Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome. International Journal of Pharmaceutical Quality Assurance, 16(12). https://doi.org/10.25258/ijpqa.16.12.61

Vancouver

Ray I, Ray B, M. D. Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome. International Journal of Pharmaceutical Quality Assurance. 2026;16(12). doi:10.25258/ijpqa.16.12.61

BibTeX
@article{Ray2026,
  author = {Ray, Ivy and Ray, Binay and M., Divya},
  title = {Correlation of Serum Myeloperoxidase and Paraoxonase 1 Levels with Atherosclerotic Risk in Metabolic Syndrome},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {16},
  number = {12},
  doi = {10.25258/ijpqa.16.12.61}
}
Kostenlos starten →